| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/19/2002 | EP1214440A2 Sequence-specific dna recombination in eukaryotic cells |
| 06/19/2002 | EP1214439A2 Smooth muscle cell promoter and uses thereof |
| 06/19/2002 | EP1214438A1 Improved methods and means for retroviral gene delivery |
| 06/19/2002 | EP1214437A1 Use of lentiviral vectors for antigen presentation in dendritic cells |
| 06/19/2002 | EP1214436A2 Wheat dp proteins and uses thereof |
| 06/19/2002 | EP1214435A2 Seed-preferred promoter from maize |
| 06/19/2002 | EP1214434A2 Enhancer elements for increased translation in plant plastids |
| 06/19/2002 | EP1214433A1 Methods and means for modification of plant flowering characteristics |
| 06/19/2002 | EP1214432A1 Transgenic manipulation of sn-glycerol-3-phosphate and glycerol production with a feedback defective glycerol-3-phosphate dehydrogenase gene |
| 06/19/2002 | EP1214431A1 Expression of proteins in genetically modified fungi |
| 06/19/2002 | EP1214430A1 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor |
| 06/19/2002 | EP1214429A1 Modulation of ige receptor cell surface expression |
| 06/19/2002 | EP1214428A1 Method for producing active serine proteases and inactive variants |
| 06/19/2002 | EP1214427A2 26176, a novel calpain protease and uses thereof |
| 06/19/2002 | EP1214425A1 Regulatory sequences and expression cassettes for yeasts |
| 06/19/2002 | EP1214423A1 Heparanase-2, a member of the heparanase protein family |
| 06/19/2002 | EP1214422A1 Phosphatases which activate map kinase pathways |
| 06/19/2002 | EP1214421A2 Stachybotrys phenol oxidizing enzyme |
| 06/19/2002 | EP1214420A2 Methods and microorganisms for production of panto-compounds |
| 06/19/2002 | EP1214418A1 Nucleic acid which is obtained from tetrahymena and which codes for a delta-6-desaturase, the production thereof and use |
| 06/19/2002 | EP1214417A2 Nucleic acids and proteins from group b streptococcus |
| 06/19/2002 | EP1214416A2 Use of replication-deficient adenoviral vector to boost cd8+ t cell immune response to antigen |
| 06/19/2002 | EP1214414A2 Rip-3-like death-associated kinase |
| 06/19/2002 | EP1214413A1 Human paralogue of a head trauma induced cytoplasmatic calcium binding protein |
| 06/19/2002 | EP1214412A1 Rgs10b, a g-protein regulator expressed in osteoclasts |
| 06/19/2002 | EP1214411A2 Flint analog compounds and formulations thereof |
| 06/19/2002 | EP1214410A1 Chimaeric plant viruses with mucin peptides |
| 06/19/2002 | EP1214409A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 06/19/2002 | EP1214408A1 Ribozymes used for restenosis prevention |
| 06/19/2002 | EP1214407A2 Method for identifying mhc-restricted antigens |
| 06/19/2002 | EP1214406A1 Method for binding nucleic acids to a solid phase |
| 06/19/2002 | EP1214405A1 Genetic screening methods |
| 06/19/2002 | EP1214404A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 06/19/2002 | EP1214403A1 Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| 06/19/2002 | EP1214402A2 Plant regulatory sequences for selective control of gene expression |
| 06/19/2002 | EP1214401A2 Dna encoding the human serine protease c-e |
| 06/19/2002 | EP1214400A2 Zymogen activation system |
| 06/19/2002 | EP1214399A1 High level cytokine production with enhanced cell viability |
| 06/19/2002 | EP1214396A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 06/19/2002 | EP1214352A2 Enhanced phage display libraries of human vh fragments and methods for producing same |
| 06/19/2002 | EP1214349A2 Secreted soluble alpha2delta-2, alpha2delta-3 or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 06/19/2002 | EP1214346A1 A novel angiogenesis inhibitor |
| 06/19/2002 | EP1214344A1 Dipeptidyl peptidases |
| 06/19/2002 | EP1214343A2 T2r taste receptor family |
| 06/19/2002 | EP1214342A1 Steroid hormone receptor polynucleotides, polypeptides, and antibodies |
| 06/19/2002 | EP1214341A1 Dendritic cell membrane protein fire |
| 06/19/2002 | EP1214339A2 Polypeptides from moraxella (branhamella) catarrhalis |
| 06/19/2002 | EP1214338A2 Cis-prenyltransferases from plants |
| 06/19/2002 | EP1214337A2 Proteins associated with cell differentiation |
| 06/19/2002 | EP1214335A1 Gamma-carboxyglutamate containing conopeptides |
| 06/19/2002 | EP1214334A1 Mutant fatty acid desaturase and methods for directed mutagenesis |
| 06/19/2002 | EP1214331A2 2-azapurine compounds and their use |
| 06/19/2002 | EP1214149A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 06/19/2002 | EP1214098A1 Capsid-modified recombinant adenovirus and methods of use |
| 06/19/2002 | EP1214097A1 Nucleic acids encoding polyepitope polypeptides |
| 06/19/2002 | EP1214091A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 06/19/2002 | EP1214089A1 Therapeutic uses of m3 polypeptide |
| 06/19/2002 | EP1214088A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 06/19/2002 | EP1214082A2 Methods and compositions for reducing immune response |
| 06/19/2002 | EP1214069A1 High affinity dna binding compounds as adjuvants in antisense technology |
| 06/19/2002 | EP1213956A1 Seedless fruit production |
| 06/19/2002 | EP1180927A4 Transformation of allium sp. with agrobacterium using embryogenic callus cultures |
| 06/19/2002 | EP1015622A4 Practical in vitro sialylation of recombinant glycoproteins |
| 06/19/2002 | EP0977846B1 Neuronal mort1 isoforms |
| 06/19/2002 | EP0900275B1 Methods and reagents for modulating apoptosis |
| 06/19/2002 | EP0879062B1 Nucleic acid delivery vehicle |
| 06/19/2002 | EP0870050B1 Toxic-protein expressing viruses and producer cell lines |
| 06/19/2002 | EP0859841B1 Protein/(poly)peptide libraries |
| 06/19/2002 | EP0854920A4 Mouse integrin subunits |
| 06/19/2002 | EP0826034A4 Generation of large genomic dna deletions |
| 06/19/2002 | EP0814831B1 Medicaments for treatment of autoimmune diseases using interferon-tau |
| 06/19/2002 | EP0804616B1 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories |
| 06/19/2002 | EP0714510B1 Natural killer cell-specific antigen and antibodies that identify the same |
| 06/19/2002 | EP0632817B1 Neurotrophic factors having altered receptor binding specificities |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0611397B1 Feline leukemia virus vaccines |
| 06/19/2002 | EP0462215B1 MOLECULAR CLONING OF GENOMIC AND cDNA SEQUENCES ENCODING CELLULAR RECEPTORS FOR POLIOVIRUS |
| 06/19/2002 | CN1354800A Recombinant newcastle disease virus RNA expression systems and vaccines |
| 06/19/2002 | CN1354797A DNA encoding plant lipase, transgenic plants and method for controlling senescence in plants |
| 06/19/2002 | CN1354796A Medical preparations for treatment of alpha-galactosidase A deficiency |
| 06/19/2002 | CN1354795A Polypeptides having lactonohydrolase activity and nucleic acids encoding same |
| 06/19/2002 | CN1354794A i(Gluconobacter suboxydans) sorbitol dehydrogenase, genes and methods of use thereof |
| 06/19/2002 | CN1354793A i(NAC1)-plant gene encoding transcription factor involved in cotyledon and lateral root development |
| 06/19/2002 | CN1354792A Biosynthesis of foreign proteins using transformed microalgae |
| 06/19/2002 | CN1354791A Compositions for treatment and diagnosis of breast cancer and methods for their use |
| 06/19/2002 | CN1354790A Transformant for screening of inhibitors for human immunodeficiency virus |
| 06/19/2002 | CN1354789A Polypeptides having choline oxidase activity and nucleic acid encoding same |
| 06/19/2002 | CN1354788A Cyclic peptides |
| 06/19/2002 | CN1354787A Process for purifying human papillomavirus virus-like particles |
| 06/19/2002 | CN1354756A MEG-4 protein |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354752A Boronic acid containing reagents and oligonucleotides |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354671A Method for inhibition of phospholamban activity for treatment of cardiac disease and heart failure |
| 06/19/2002 | CN1354668A Isolated peptides which bind to HLA-B35 molecules |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354254A Gametophyte pollen self-incompatibity gene and its application |
| 06/19/2002 | CN1354253A Dilutus culex trypsase gene |
| 06/19/2002 | CN1354186A Preparation method of recombinant human vascular endothelial cytopoiesis suppressor factor with human LgG1Fc fragment molecular structure and application of its product |
| 06/19/2002 | CN1354185A A novel polypeptide-Krev-1/rapla conjugated protein KRIT 134.87 and polynucleotide coding said polypeptide |